| Course | PS516 Psychopharmacology |
|---|---|
| Unit | Unit 2 |
| Paper type | Drug-receptor interactions paper |
| Length | About 1,120 words, 7 pages double-spaced |
| Format | APA 7 student paper |
| School | Purdue University Global |
| Program | MS in Psychology |
| Updated | October 2026 |
Free sample paper for PS516 Unit 2
Full, Partial and Blocked: A PS516 Unit 2 Paper Explaining Drug-Receptor Interactions and Dose-Response Through Three Opioid Medicines and Lithium
[Student Name]
Purdue University Global
PS516: Psychopharmacology
Unit 2 Drug-Receptor Interactions Paper
[Instructor Name]
[Date]
The writer, the clinic and the clients mentioned are composite and illustrative; the sources cited are real.
Why a Nonprescriber Needs This
I do not prescribe, but I see clients more often than our nurse practitioner does, and they ask me questions about their medicines between visits. Why does a client on buprenorphine say a pill bought on the street "didn't do anything"? Why does the nurse practitioner insist that a client on lithium get blood drawn every few months? Answering those questions accurately, and knowing when to pass them on, requires understanding how drugs act at receptors and how their effects change with dose. This paper explains those concepts through the medicines our clients take.
Receptors and What Drugs Do There
A receptor is a protein on or in a cell that responds when a particular molecule binds to it. Stahl (2021) describes most psychiatric drugs as acting at a small number of sites: receptors for neurotransmitters, transporters that clear neurotransmitters from the synapse, enzymes that break them down and ion channels. Two properties of a drug at a receptor matter most for clinical work. Affinity is how strongly the drug attaches. Intrinsic activity, or efficacy, is how much the receptor responds once the drug is attached.
Those two properties sort drugs into families. A full agonist both attaches and switches the receptor fully on. An antagonist attaches but produces no activity of its own, and by sitting on the receptor it blocks other molecules from acting there. A partial agonist sits between the two: it attaches and switches the receptor on, but only partway, no matter how much is given.
Three Opioid Medicines
Our clinic's three opioid-related medicines illustrate all three families at the mu opioid receptor.
Methadone is a full agonist. At higher doses it produces more effect, including more slowing of breathing, which is why methadone doses are increased slowly and why combining it with alcohol or sedatives is dangerous.
Naloxone, which we give to every client in opioid treatment and their families, is an antagonist with high affinity. Sprayed into the nose during an overdose, it pushes opioids off the receptor and restores breathing within minutes. It has no opioid effect of its own, so it cannot cause a high or harm someone who has not taken opioids.
Buprenorphine is a partial agonist with very high affinity. Walsh et al. (1994) gave volunteers increasing doses and found that its effects rose at low doses and then leveled off, so that higher doses produced little added effect on breathing or on subjective feelings. That ceiling makes buprenorphine safer than full agonists when taken alone.
Buprenorphine's ceiling is not a weakness of the drug; it is the reason a person can take it at home with less risk of stopping breathing.
High affinity explains the client who said a street pill "didn't do anything." Buprenorphine holds the receptor so tightly that a later dose of another opioid has trouble displacing it. The same property explains why starting buprenorphine while a full agonist is still in the body can trigger sudden withdrawal: buprenorphine pushes off the full agonist and replaces it with a weaker effect. That is why our nurse practitioner asks clients to wait until they feel early withdrawal before the first dose.
A Different Kind of Action: Benzodiazepines
Not every drug acts by switching a receptor on or off. Benzodiazepines bind to a site on the GABA-A receptor separate from where GABA itself binds and make the receptor respond more strongly when GABA is present. Stahl (2021) calls this kind of drug a positive allosteric modulator. Lader (2011) reviews how this action produces calm and sleep and also why long-term use leads to tolerance and dependence. Alcohol also enhances GABA-A activity, which is part of why benzodiazepines and alcohol together are especially dangerous, a point I will return to in Unit 4.
Dose-Response
A dose-response curve plots the size of a drug's effect against its dose. For most drugs the curve rises steeply over a middle range and then flattens. Two features of the curve matter clinically. Potency describes how much drug is needed to produce a given effect; a potent drug works at a low dose. Efficacy describes the maximum effect a drug can produce at any dose. Buprenorphine is very potent, active at a fraction of a milligram, but has lower maximum efficacy than methadone, which is the ceiling Walsh and colleagues measured.
Each effect of a drug has its own curve. A medicine may relieve symptoms at a dose well below the dose that causes side effects, or the curves may overlap. This is why the same drug can be well tolerated by one client and not another, and why dose changes should always go through the prescriber.
The Therapeutic Index and Lithium
The therapeutic index is a ratio: how much drug it takes to poison someone, set against how much it takes to help. A wide index means there is a large margin between helping and harming. A narrow index means the margin is small, and levels must be monitored. Lithium, used for bipolar disorder, has a narrow index: the level in the blood that keeps episodes away sits only a short step below the level that makes people sick. Stahl (2021) notes that anything that changes how the body clears lithium, such as dehydration or certain pain relievers, can push levels into the toxic range. For a client who works the summer wheat harvest in eastern Washington heat, that is not a theoretical concern.
What I Do With This
Understanding these concepts changes what I say and what I pass on. When a client on buprenorphine asks about adding a sleeping pill, I explain why the nurse practitioner needs to know about any sedative. When a client on lithium mentions a long stretch of hot shifts or a new pain medicine, I ask the nurse practitioner whether a level should be checked. When a family asks whether naloxone could hurt someone, I can tell them it has no effect without opioids present.
Conclusion
Affinity and intrinsic activity sort drugs into full agonists, partial agonists and antagonists, and our clinic's opioid medicines show all three. Walsh and colleagues' ceiling effect explains buprenorphine's safety, high affinity explains both its blocking effect and the risk of precipitated withdrawal, and dose-response curves and the therapeutic index explain why lithium needs monitoring. For a nonprescriber, these ideas are the basis for accurate answers and timely referrals.
References
Lader, M. (2011). Benzodiazepines revisited: Will we ever learn? Addiction, 106(12), 2086-2109. https://doi.org/10.1111/j.1360-0443.2011.03563.x
Stahl, S. M. (2021). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press.
Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994). Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clinical Pharmacology and Therapeutics, 55(5), 569-580. https://doi.org/10.1038/clpt.1994.71
PS516 Unit 2 instructions, in plain terms
Unit 2 of PS516 asks you to explain drug-receptor interactions and dose-response using real medications. Define affinity and intrinsic activity, then explain full agonists, partial agonists and antagonists, using one medication for each and citing a pharmacology text or primary study. Describe at least one drug that acts by modulating a receptor rather than switching it on or off. Explain dose-response curves, potency, efficacy and the therapeutic index, with an example of a drug whose index is narrow. Throughout, connect each concept to something a nonprescriber would see in practice, such as a client's question or a safety concern. Conclude with how understanding these concepts changes what you say to clients and what you pass on to the prescriber.
How the PS 516 Unit 2 example is put together
The paper opens with questions clients ask between prescriber visits. A section defines receptors, affinity and intrinsic activity and sorts drugs into three families. Three paragraphs place methadone, naloxone and buprenorphine in those families, using Walsh and colleagues to explain the ceiling effect, under a highlighted line about that ceiling as a safety feature. A paragraph explains high affinity, blocked street pills and precipitated withdrawal. A section on benzodiazepines introduces allosteric modulation with Stahl and Lader. Sections on dose-response and the therapeutic index end with lithium and harvest heat. A section on what the care manager does with this knowledge precedes the conclusion.
PS516 Unit 2 rubric: what earns full points
The rubric rewards accurate definitions of affinity, intrinsic activity and the three families of receptor action, each illustrated with a correct example. Papers earn more credit when they explain clinical consequences of these properties, such as why a partial agonist has a ceiling or why high affinity can cause precipitated withdrawal. Including a drug that acts by modulation shows breadth. Dose-response concepts should be distinguished clearly, especially potency from efficacy, and the therapeutic index should be tied to a monitoring need. Connecting each concept to the nonprescriber's work shows the applied understanding the course wants. Clear organization and correct citations of the text and studies complete a strong paper.
Common PS516 Unit 2 mistakes, and how to avoid them
The most common Unit 2 error is confusing potency with efficacy, for example calling a drug stronger because it works at a smaller dose. Another is describing a partial agonist as a weak drug instead of one with a limited maximum effect. Students often list definitions with no medications attached, or attach the wrong medication to a category. Some papers drift into dosing advice, which falls outside a counselor's role. Before submitting, check that each of the three receptor families has a correct example, that potency and efficacy are defined separately, that you name one drug with a narrow therapeutic index and why it needs monitoring and that every concept leads to something you would say or report.
Get a PS516 Unit 2 example written to your instructions
Share the instructions and the rubric. A custom paper explains agonists, antagonists and dose-response through real drugs. The first is free, delivered within 24-48h. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
More PS516 papers and MS in Psychology samples
- PS516 Unit 1: Neurotransmitters Post
- PS516 Unit 3: Antidepressant Case Paper
- PS516 Unit 4: Discussion Board Post
- PS516 Unit 5: Antipsychotic Case Paper
- PS516 Unit 6: Mood Stabilizer Case Paper
- PS516 Unit 7: Stimulant Medication Paper
- PS516 Unit 8: Discussion Board Post
- PS516 Unit 9: Research Evaluation Paper
- PS516 Unit 10: Interdisciplinary Case Plan
- PS501 Unit 2: Inclusive Writing Paper
- PS511 Unit 2: Neurobiology of Addiction Paper
- PS508 Unit 2: Boundaries and Dual Relationships Paper
PS516 Unit 2 questions, answered
What is a partial agonist?
A drug that activates a receptor but produces less than the full effect, even at high doses.
What is a ceiling effect?
A point beyond which higher doses add little effect, as with buprenorphine's effect on breathing.
What is the therapeutic index?
The gap between the dose that helps and the dose that harms; a narrow index calls for careful monitoring.
Where can I find a free PS516 Unit 2 sample paper?
The full PS516 Unit 2 paper on agonists, partial agonists, antagonists and dose-response through clinic medicines is printed above.
Why does buprenorphine block other opioids in the PS516 Unit 2 sample?
Its very high affinity means it holds the receptor so tightly that a later opioid dose has trouble displacing it.